Carolina R den Hartog1, Katrina L Blandino1, McKenzie L Nash1, Emily R Sjogren1, Michael A Grampetro1, David E Moorman2, Elena M Vazey3. 1. Department of Biology, University of Massachusetts Amherst, 611 North Pleasant St, Amherst, MA, 01003, USA. 2. Department of Psychological and Brain Sciences, University of Massachusetts Amherst, Amherst, MA, 01003, USA. 3. Department of Biology, University of Massachusetts Amherst, 611 North Pleasant St, Amherst, MA, 01003, USA. evazey@umass.edu.
Abstract
RATIONALE: Stress plays a major role in the development of alcohol use disorder (AUD)-a history of chronic stress contributes to alcohol misuse, and withdrawal from alcohol elevates stress, perpetuating cycles of problematic drinking. Recent studies have shown that, in male mice, repeated chronic intermittent ethanol (CIE) and stress elevates alcohol use above either manipulation alone and impacts cognitive functions such as behavioral flexibility. OBJECTIVE: Here, we investigated the impact of CIE and stress on anxiety in both sexes, and whether the norepinephrine (NE) system via locus coeruleus, which is implicated in both stress and alcohol motivation, is involved. RESULTS: Male and female mice received multiple cycles of CIE and/or repeated forced swim stress (FSS), producing elevated drinking in both sexes. CIE/FSS treatment increased anxiety, which was blocked by treatment with the α1-AR inverse agonist prazosin. In contrast, administration of the corticotropin releasing factor receptor antagonist CP376395 into locus coeruleus did not reduce CIE/FSS-elevated anxiety. We also observed sex differences in behavioral responses to a history of CIE or FSS alone as well as differential behavioral consequences of prazosin treatment. CONCLUSIONS: These data indicate that NE contributes to the development of anxiety following a history of alcohol and/or stress, and that the influence of both treatment history and NE signaling is sex dependent. These results argue for further investigation of the NE system in relation to disrupted behavior following chronic alcohol and stress, and support the assertion that treatments may differ across sex based on differential neural system engagement.
RATIONALE: Stress plays a major role in the development of alcohol use disorder (AUD)-a history of chronic stress contributes to alcohol misuse, and withdrawal from alcohol elevates stress, perpetuating cycles of problematic drinking. Recent studies have shown that, in male mice, repeated chronic intermittent ethanol (CIE) and stress elevates alcohol use above either manipulation alone and impacts cognitive functions such as behavioral flexibility. OBJECTIVE: Here, we investigated the impact of CIE and stress on anxiety in both sexes, and whether the norepinephrine (NE) system via locus coeruleus, which is implicated in both stress and alcohol motivation, is involved. RESULTS: Male and female mice received multiple cycles of CIE and/or repeated forced swim stress (FSS), producing elevated drinking in both sexes. CIE/FSS treatment increased anxiety, which was blocked by treatment with the α1-AR inverse agonist prazosin. In contrast, administration of the corticotropin releasing factor receptor antagonist CP376395 into locus coeruleus did not reduce CIE/FSS-elevated anxiety. We also observed sex differences in behavioral responses to a history of CIE or FSS alone as well as differential behavioral consequences of prazosin treatment. CONCLUSIONS: These data indicate that NE contributes to the development of anxiety following a history of alcohol and/or stress, and that the influence of both treatment history and NE signaling is sex dependent. These results argue for further investigation of the NE system in relation to disrupted behavior following chronic alcohol and stress, and support the assertion that treatments may differ across sex based on differential neural system engagement.
Entities:
Keywords:
Alcohol; Anxiety; CRF; Locus coeruleus; Noradrenaline; Prazosin; Sex differences
Authors: Janice C Froehlich; Brett Hausauer; Stephen Fischer; Bradley Wise; Dennis D Rasmussen Journal: Alcohol Clin Exp Res Date: 2015-08 Impact factor: 3.455
Authors: Helen C Fox; George M Anderson; Keri Tuit; Julie Hansen; Anne Kimmerling; Kristen M Siedlarz; Peter T Morgan; Rajita Sinha Journal: Alcohol Clin Exp Res Date: 2011-09-15 Impact factor: 3.455
Authors: Solal Bloch; Katherine M Holleran; Thomas L Kash; Elena M Vazey; Jennifer A Rinker; Christina L Lebonville; Krysten O'Hara; Marcelo F Lopez; Sara R Jones; Kathleen A Grant; Howard C Becker; Patrick J Mulholland Journal: Alcohol Date: 2022-02-15 Impact factor: 2.405
Authors: Ana Paula S Dornellas; Nathan W Burnham; Kendall L Luhn; Maxwell V Petruzzi; Todd E Thiele; Montserrat Navarro Journal: Neuropharmacology Date: 2021-09-20 Impact factor: 5.250
Authors: Harold L Haun; Christina L Lebonville; Matthew G Solomon; William C Griffin; Marcelo F Lopez; Howard C Becker Journal: Biol Psychiatry Date: 2022-01-10 Impact factor: 12.810
Authors: Reginald Cannady; Tiffany Nguyen; Audrey E Padula; Jennifer A Rinker; Marcelo F Lopez; Howard C Becker; John J Woodward; Patrick J Mulholland Journal: Neuropharmacology Date: 2020-11-09 Impact factor: 5.250
Authors: Wojciech B Solecki; Michał Kielbinski; Michał Wilczkowski; Katarzyna Zajda; Karolina Karwowska; Bernacka Joanna; Zenon Rajfur; Ryszard Przewłocki Journal: Front Neurosci Date: 2022-08-05 Impact factor: 5.152
Authors: Audrey E Padula; Jennifer A Rinker; Marcelo F Lopez; Megan K Mulligan; Robert W Williams; Howard C Becker; Patrick J Mulholland Journal: Transl Psychiatry Date: 2020-11-27 Impact factor: 7.989